Search

Jennifer E. Graser

Examiner (ID: 15, Phone: (571)272-0858 , Office: P/1645 )

Most Active Art Unit
1645
Art Unit(s)
1645, 1802, 1641, 1621
Total Applications
1979
Issued Applications
1306
Pending Applications
236
Abandoned Applications
472

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 19043587 [patent_doc_number] => 11932671 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-03-19 [patent_title] => Modified meningococcal fHbp polypeptides [patent_app_type] => utility [patent_app_number] => 17/245681 [patent_app_country] => US [patent_app_date] => 2021-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 8 [patent_no_of_words] => 23491 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 142 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17245681 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/245681
Modified meningococcal fHbp polypeptides Apr 29, 2021 Issued
Array ( [id] => 17185224 [patent_doc_number] => 20210332109 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-10-28 [patent_title] => ANTI-VARICELLA-ZOSTER VIRUS ANTIBODY, IMMUNOLOGICAL MEASUREMENT METHOD, AND IMMUNOLOGICAL MEASUREMENT DEVICE [patent_app_type] => utility [patent_app_number] => 17/240580 [patent_app_country] => US [patent_app_date] => 2021-04-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19027 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 87 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17240580 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/240580
Anti-varicella-zoster virus antibody, immunological measurement method, and immunological measurement device Apr 25, 2021 Issued
Array ( [id] => 18364366 [patent_doc_number] => 20230145957 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-05-11 [patent_title] => A VACCINE TO PROTECT AGAINST MYCOPLASMA HYOPNEUMONIAE [patent_app_type] => utility [patent_app_number] => 17/917987 [patent_app_country] => US [patent_app_date] => 2021-04-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4887 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17917987 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/917987
Vaccine to protect against mycoplasma hyopneumoniae Apr 18, 2021 Issued
Array ( [id] => 20451868 [patent_doc_number] => 12514912 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2026-01-06 [patent_title] => Compositions comprising three OspA fusion proteins for medical use [patent_app_type] => utility [patent_app_number] => 17/917624 [patent_app_country] => US [patent_app_date] => 2021-04-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 35 [patent_figures_cnt] => 37 [patent_no_of_words] => 14601 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 163 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17917624 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/917624
Compositions comprising three OspA fusion proteins for medical use Apr 8, 2021 Issued
Array ( [id] => 17170385 [patent_doc_number] => 20210324055 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-10-21 [patent_title] => Methods, Devices, Kits and Compositions for Detecting Tapeworm [patent_app_type] => utility [patent_app_number] => 17/224544 [patent_app_country] => US [patent_app_date] => 2021-04-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26480 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -28 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17224544 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/224544
Methods, Devices, Kits and Compositions for Detecting Tapeworm Apr 6, 2021 Abandoned
Array ( [id] => 20372663 [patent_doc_number] => 12480089 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-11-25 [patent_title] => Antiviral treatment comprising Blis containing probiotic products [patent_app_type] => utility [patent_app_number] => 17/916421 [patent_app_country] => US [patent_app_date] => 2021-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 10721 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 94 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17916421 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/916421
Antiviral treatment comprising Blis containing probiotic products Mar 30, 2021 Issued
Array ( [id] => 17156469 [patent_doc_number] => 20210317520 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-10-14 [patent_title] => MUTANT PORES [patent_app_type] => utility [patent_app_number] => 17/215506 [patent_app_country] => US [patent_app_date] => 2021-03-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 58711 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -7 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17215506 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/215506
Mutant pores Mar 28, 2021 Issued
Array ( [id] => 18496138 [patent_doc_number] => 20230218684 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-07-13 [patent_title] => ENGINEERED BACTERIA FOR USE IN VACCINE COMPOSITIONS [patent_app_type] => utility [patent_app_number] => 17/995069 [patent_app_country] => US [patent_app_date] => 2021-03-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14238 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -33 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17995069 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/995069
ENGINEERED BACTERIA FOR USE IN VACCINE COMPOSITIONS Mar 28, 2021 Pending
Array ( [id] => 17141736 [patent_doc_number] => 20210309748 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-10-07 [patent_title] => ANTI HLA-G SPECIFIC ANTIBODIES [patent_app_type] => utility [patent_app_number] => 17/212165 [patent_app_country] => US [patent_app_date] => 2021-03-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17351 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -5 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17212165 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/212165
ANTI HLA-G SPECIFIC ANTIBODIES Mar 24, 2021 Abandoned
Array ( [id] => 18436423 [patent_doc_number] => 20230183717 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-06-15 [patent_title] => POLYPEPTIDES WITH PEROXIDASE ACTIVITY [patent_app_type] => utility [patent_app_number] => 17/914215 [patent_app_country] => US [patent_app_date] => 2021-03-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12668 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 68 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17914215 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/914215
Polypeptides with peroxidase activity Mar 23, 2021 Issued
Array ( [id] => 18461665 [patent_doc_number] => 11685949 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-06-27 [patent_title] => Mutant pore [patent_app_type] => utility [patent_app_number] => 17/194472 [patent_app_country] => US [patent_app_date] => 2021-03-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 46 [patent_figures_cnt] => 64 [patent_no_of_words] => 58917 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17194472 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/194472
Mutant pore Mar 7, 2021 Issued
Array ( [id] => 18461665 [patent_doc_number] => 11685949 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-06-27 [patent_title] => Mutant pore [patent_app_type] => utility [patent_app_number] => 17/194472 [patent_app_country] => US [patent_app_date] => 2021-03-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 46 [patent_figures_cnt] => 64 [patent_no_of_words] => 58917 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17194472 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/194472
Mutant pore Mar 7, 2021 Issued
Array ( [id] => 17050725 [patent_doc_number] => 20210260159 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-08-26 [patent_title] => CD40L-Fc FUSION POLYPEPTIDES AND METHODS OF USE THEREOF [patent_app_type] => utility [patent_app_number] => 17/194658 [patent_app_country] => US [patent_app_date] => 2021-03-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16844 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17194658 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/194658
CD40L-Fc FUSION POLYPEPTIDES AND METHODS OF USE THEREOF Mar 7, 2021 Abandoned
Array ( [id] => 16946741 [patent_doc_number] => 20210205432 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-07-08 [patent_title] => PROTEINS AND IMMUNIZING COMPOSITIONS CONTAINING PASTEURELLA PROTEINS AND METHODS OF USE [patent_app_type] => utility [patent_app_number] => 17/191913 [patent_app_country] => US [patent_app_date] => 2021-03-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26774 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -8 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17191913 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/191913
Proteins and immunizing compositions containing Mar 3, 2021 Issued
Array ( [id] => 18531101 [patent_doc_number] => 20230236172 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-07-27 [patent_title] => T Cells That Respond To Patient Neoepitopes [patent_app_type] => utility [patent_app_number] => 17/906782 [patent_app_country] => US [patent_app_date] => 2021-03-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4980 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 92 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17906782 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/906782
T Cells That Respond To Patient Neoepitopes Mar 3, 2021 Abandoned
Array ( [id] => 18307699 [patent_doc_number] => 20230111599 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-04-13 [patent_title] => VACCINES COMPRISING GLYCOENGINEERED BACTERIA [patent_app_type] => utility [patent_app_number] => 17/908829 [patent_app_country] => US [patent_app_date] => 2021-03-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23921 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -37 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17908829 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/908829
VACCINES COMPRISING GLYCOENGINEERED BACTERIA Mar 2, 2021 Pending
Array ( [id] => 17080642 [patent_doc_number] => 20210275648 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-09-09 [patent_title] => SOUTHERN CATTLE TICK VACCINE PRODUCT [patent_app_type] => utility [patent_app_number] => 17/190235 [patent_app_country] => US [patent_app_date] => 2021-03-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12672 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -20 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17190235 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/190235
Southern cattle tick vaccine product Mar 1, 2021 Issued
Array ( [id] => 18349479 [patent_doc_number] => 20230137590 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-05-04 [patent_title] => COMPOSITIONS AND METHODS FOR PRODUCING DISEASE SUPPRESSION [patent_app_type] => utility [patent_app_number] => 17/908514 [patent_app_country] => US [patent_app_date] => 2021-03-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22965 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17908514 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/908514
COMPOSITIONS AND METHODS FOR PRODUCING DISEASE SUPPRESSION Mar 1, 2021 Pending
Array ( [id] => 18449647 [patent_doc_number] => 20230190923 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-06-22 [patent_title] => COMPOSITIONS COMPRISING LTB AND PATHOGENIC ANTIGENS, AND USE THEREOF [patent_app_type] => utility [patent_app_number] => 17/802465 [patent_app_country] => US [patent_app_date] => 2021-02-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21768 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17802465 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/802465
COMPOSITIONS COMPRISING LTB AND PATHOGENIC ANTIGENS, AND USE THEREOF Feb 24, 2021 Abandoned
Array ( [id] => 19140512 [patent_doc_number] => 20240139302 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-05-02 [patent_title] => PROPIONIBACTERIUM ACNES PROPHYLACTIC AND THERAPEUTIC IMMUNE TREATMENT [patent_app_type] => utility [patent_app_number] => 17/801099 [patent_app_country] => US [patent_app_date] => 2021-02-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 136575 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -23 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17801099 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/801099
PROPIONIBACTERIUM ACNES PROPHYLACTIC AND THERAPEUTIC IMMUNE TREATMENT Feb 21, 2021 Pending
Menu